Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Rabies Vaccine, Human
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Rabivax-S
Product Type : Vaccine
Upfront Cash : Inapplicable
July 10, 2023
Lead Product(s) : Rabies Vaccine, Human
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 01, 2021
Lead Product(s) : Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Live Varicella Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Skyvaricella
Product Type : Vaccine
Upfront Cash : Inapplicable
May 12, 2020
Lead Product(s) : Live Varicella Virus Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Recipient : Vietnam Military Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Vingroup Innovation Foundation
Deal Size : $0.3 million
Deal Type : Funding
Vietnam’s Vingroup funds three coronavirus research projects
Details : With this funding, Vabiotech will be developing vaccines against the novel coronavirus (Covid-19) on growing medium of Baculoviruses at laboratory scale led by Dr. Do Tuan Dat.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
February 21, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Vingroup Innovation Foundation
Deal Size : $0.3 million
Deal Type : Funding
Lead Product(s) : Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
April 30, 2019
Lead Product(s) : Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Vietstar Biomedical Research
Deal Size : Inapplicable
Deal Type : Inapplicable